James M. Hoffman
Title
Cited by
Cited by
Year
Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers
HM Dunnenberger, KR Crews, JM Hoffman, KE Caudle, U Broeckel, ...
Annual review of pharmacology and toxicology 55, 89-106, 2015
2972015
Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process
K E Caudle, T E Klein, J M Hoffman, D J Muller, M Whirl-Carrillo, L Gong, ...
Current drug metabolism 15 (2), 209-217, 2014
2832014
Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)
KE Caudle, HM Dunnenberger, RR Freimuth, JF Peterson, JD Burlison, ...
Genetics in Medicine 19 (2), 215-223, 2017
2612017
Economic evaluations of clinical pharmacy services: 2001–2005
F Doloresco, JM Hoffman, PD Meek
Pharmacotherapy 28 (11), 285e-323e, 2008
2002008
Development and use of active clinical decision support for preemptive pharmacogenomics
GC Bell, KR Crews, MR Wilkinson, CE Haidar, JK Hicks, DK Baker, ...
Journal of the American Medical Informatics Association 21 (e1), e93-e99, 2014
1772014
PG4KDS: a model for the clinical implementation of pre‐emptive pharmacogenetics
JM Hoffman, CE Haidar, MR Wilkinson, KR Crews, DK Baker, ...
American Journal of Medical Genetics Part C: Seminars in Medical Genetics …, 2014
1712014
NCCN Biosimilars White Paper: regulatory, scientific, and patient safety perspectives
AD Zelenetz, I Ahmed, EL Braud, JD Cross, N Davenport-Ennis, ...
Journal of the National Comprehensive Cancer Network 9 (Suppl_4), S-1-S-22, 2011
1712011
Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza
AH Gaur, B Bagga, S Barman, R Hayden, A Lamptey, JM Hoffman, ...
New England journal of medicine 362 (1), 88-89, 2010
1682010
Development and implementation of a pharmacist-managed clinical pharmacogenetics service
KR Crews, SJ Cross, JN McCormick, DK Baker, AR Molinelli, R Mullins, ...
American Journal of Health-System Pharmacy 68 (2), 143-150, 2011
1362011
Economic evaluations of clinical pharmacy services: 2006–2010
DR Touchette, F Doloresco, KJ Suda, A Perez, S Turner, Y Jalundhwala, ...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34 (8 …, 2014
1272014
Medication errors caused by confusion of drug names
JM Hoffman, SM Proulx
Drug safety 26 (7), 445-452, 2003
1252003
Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA‐B Genotype and Abacavir Dosing: 2014 Update
MA Martin, JM Hoffman, RR Freimuth, TE Klein, BJ Dong, M Pirmohamed, ...
Clinical Pharmacology & Therapeutics 95 (5), 499-500, 2014
1072014
National survey on the effect of oncology drug shortages on cancer care
A McBride, LM Holle, C Westendorf, M Sidebottom, N Griffith, RJ Muller, ...
American journal of health-system pharmacy 70 (7), 609-617, 2013
982013
A clinician‐driven automated system for integration of pharmacogenetic interpretations into an electronic medical record
JK Hicks, KR Crews, JM Hoffman, NM Kornegay, MR Wilkinson, R Lorier, ...
Clinical Pharmacology & Therapeutics 92 (5), 563-566, 2012
942012
The second victim experience and support tool (SVEST): validation of an organizational resource for assessing second victim effects and the quality of support resources
JD Burlison, SD Scott, EK Browne, SG Thompson, JM Hoffman
Journal of patient safety 13 (2), 93, 2017
842017
Developing knowledge resources to support precision medicine: principles from the Clinical Pharmacogenetics Implementation Consortium (CPIC)
JM Hoffman, HM Dunnenberger, J Kevin Hicks, KE Caudle, ...
Journal of the American Medical Informatics Association 23 (4), 796-801, 2016
732016
ASHP guidelines on preventing medication errors with chemotherapy and biotherapy
B Goldspiel, JM Hoffman, NL Griffith, S Goodin, R DeChristoforo, ...
American Journal of Health-System Pharmacy 72 (8), e6-e35, 2015
702015
Patient safety culture and the second victim phenomenon: connecting culture to staff distress in nurses
RR Quillivan, JD Burlison, EK Browne, SD Scott, JM Hoffman
The Joint Commission Journal on Quality and Patient Safety 42 (8), 377-AP2, 2016
692016
Biosimilars: implications for health-system pharmacists
SD Lucio, JG Stevenson, JM Hoffman
American journal of health-system pharmacy 70 (22), 2004-2017, 2013
692013
Projecting future drug expenditures—2012
JM Hoffman, E Li, F Doloresco, L Matusiak, RJ Hunkler, ND Shah, ...
American Journal of Health-System Pharmacy 69 (5), 405-421, 2012
692012
The system can't perform the operation now. Try again later.
Articles 1–20